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Neutrophilic  granulocytes,  upon  interacting  with  IgG  immune  complexes, 
respond in a  variety of ways, including phagocytosis of the bound particles (1, 
2),  generation  of a  respiratory  burst  producing  superoxide  (02-)  and  other 
reactive oxygen species (3), degranulation (4,  5) and ADCC (6,  7).  Because the 
initiation of these events follows immune complex binding to plasma membrane 
FcR, analysis of the molecular nature of the FcR is fundamental to understanding 
these processes. An FcR for IgG on human neutrophils has been identified using 
an mAb (3G8) that inhibits IgG binding to the cells and precipitates a 51-73 kD 
molecule (8). Eosinophils, by contrast, bear a 43 kD FcR, which has been purified 
by affinity adsorption to IgG (9). 
We have recently developed an mAb (IV3) that identifies on human monocytes, 
platelets, U937, and K562 cells a  40 kD FcR with low affinity for IgG (10-12), 
distinct from the 72 kD high-affinity FcR described on monocytes (13,  14), and 
distinct from the FcR on neutrophils recognized by mAb 3G8 (8). This antibody 
inhibits ligand binding to the 40 kD receptor, and on platelets, when crosslinked 
with a  second antibody, causes platelet aggregation (12).  Herein, we show that 
this antibody  identifies a  second  class  of FcR on  human  neutrophiIs,  distinct 
from the molecule recognized by 3G8. The antibody also binds to eosinophils. 
Materials and Methods 
Chemicals and Reagents.  Cytochrome C Type VI, superoxide dismutase, cytochalasin 
B, pepstatin, chymostatin, leupeptin, antipain, rabbit muscle actin, PMSF, and diisopro- 
pylfluorophosphate (DFP) 1 were purchased from Sigma Chemical Co., St.  Louis, MO; 
Dextran  T500,  Ficoll-Paque,  Sepharose  4  B,  CNBr-activated  Sepharose,  protein  A- 
Sepharose CL-4 B from Pharmacia Fine Chemicals, Piscataway, N  J; ox erythrocytes from 
Colorado Serum Co., Denver, CO; tetanus toxin and papain from Calbiochem-Behring, 
La Jolla, CA; human anti-tetanus toxin antibody (Hyper-Tet) from Cutter Laboratories, 
Berkeley, CA; chloroglycouril from Pierce Chemical Co., Rockford, IL; carrier-free Na125I 
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(IMS.300) from Amersham Corp., Arlington Heights, IL; affinity-purified goat F(ab')2 
anti-murine Ig (anti-mIg), both fluoresceinated (FITC) and not, from Cappel Laborato- 
ries,  Cockranville, PA;  RPMI  1640  from Gibco Laboratories, Grand  Island,  NY; FCS 
from Sterile Systems, Logan, UT; and a mixture of low molecular weight markers from 
Biorad Laboratories, Richmond, CA. Other chemicals were of analytical grade and were 
obtained commercially. 
NP-40 lysis buffer contained 1% NP-40, 20 mM Tris,  110 mM NaCI, 10 mM EDTA, 
2 mM PMSF,  10 #g]ml pepstatin,  10/tg]ml chymostatin,  10/tg/ml leupeptin,  10 ~tg/ml 
antipain, pH 7.1.  Krebs Ringer phosphate (KRP) buffer consisted of 130  mM NaCI, 5 
mM KCI, 1.2  mM MgSO4,  1 mM CaCI~, and 10 mM sodium phosphate buffer, pH 7.4. 
PBS was 145 mM NaCI in 20 mM phosphate buffer, pH 7.0. PBS-K contained 130 mM 
NaCI and 5 mM KCI in 10 mM phosphate buffer, pH 7.4. 
The preparation and properties of mAb IV3 have been described (10-12).  IV3 was 
used either as supernatant fluid from the culture of cloned cells or as IgG purified from 
ascites fluid by (NH4)2SO4 precipitation and ion-exchange chromatography. Fab fragments 
were made by digesting a 5 mg/ml solution in PBS containing 10 mM cysteine and 5 mM 
EDTA with papain (1:50 papain/protein) for 30 min at 37°C, and acetylating  with  20 
mM iodoacetamide. The digest was passed over a protein A-Sepharose column and was 
analyzed by SDS-PAGE. No intact IgG remained. IgG fractions of murine or myeloma 
mAb 3G8 (IgG 1) (8), MOPC 141 (IgG2b), and anti-VK3b (IgG2b) (15) were purified from 
ascites  fluids  by  ion-exchange  chromatography.  Purified  IgG  from  mAb  AML-2-23 
(IgG2b) was generously provided by Dr.  Michael  Fanger,  Dartmouth  Medical  School, 
Hanover, NH (16). 
Immune complexes containing human IgG were prepared by incubating tetanus toxin 
(200  Lf/ml) with  Hyper-Tet (200  Lf/ml) for  1 h  at  37°C.  Insoluble complexes were 
pelleted by centrifugation at  13,000 g  for  1 rain, washed once with PBS-K, and resus- 
pended in the original volume of PBS-K. Protein concentration was determined by adding 
0.1  M NaOH and measuring absorbance at 280 nm, assuming an extinction coefficient 
(1%) of 14. Pooled human IgG purified by ion-exchange chromatography was covalently 
linked to Sepharose 4 B by a modification of the CNBr technique (17) at 7.6 mg IgG/ml 
Sepharose. Anti-mlg was linked to CNBr-activated Sepharose according to the manufac- 
turer's instructions at 1 mg protein/ml Sepharose. Before use, the Sepharose adsorbants 
were washed four times with  1% NP-40 in PBS containing 5 mM KI. 
Cells.  Human granulocytes were obtained from the peripheral blood of normal donors 
by separation from mononuclear cells on FicolI-Hypaque, sedimentaton of erythrocytes 
using 3 % dextran in PBS, and finally hypotonic lysis of residual erythrocytes. Preparations 
were >98% granulocytes. Most donors had normal numbers of eosinophils; the two used 
for the experiments of Fig.  1 and Table I  had mild eosinophilia secondary to allergic 
rhinitis. Eosinophils for the experiments of Table II were obtained from the peripheral 
blood of a patient with idiopathic hypereosinophilic syndrome by dextran sedimentation 
and hypotonic lysis of erythrocytes. K562 cells,  a  myeloblastic line (18), were grown in 
stationary cultures as described (10). The cells were washed three times in PBS or PBS-K 
before use. 
Radiolabeling  and  Affinity  Adsorption.  Granulocytes  and  K562  cells  were  surface- 
radioiodinated  by the  chloroglycouril method (19).  0.7  ml cells in  PBS at  1.43  ×  107 
cells/ml were incubated with  1 mCi ~'sI for 30 min at 0°C in a  scintillation vial coated 
with 5 ttg chloroglycouril. The reaction was quenched and the cells were washed three 
times with 5 mM KI in PBS. The cells were then lysed in NP-40 lysis buffer for 30 min 
at 0°C.  For some experiments 2 mM DFP was added to the lysis buffer. Cell nuclei and 
other insoluble material were pelleted by centrifugation at 7,800 g for 20 rain. Portions 
of labeled cell lysate (50 ¢tl) were incubated for 1 h at 0 °C with 50 ttl mAb (IV3 supernatant, 
3G8 IgG at 10 ~tg/ml,  or a murine lgG2b myeloma, MOPC141, at 10 ttg/ml), and then 
with 25 ttl Sepharose-anti-mlg. Separate 50-~d portions of lysate were incubated with 25 
ttl Sepharose-human IgG. The Sepharose conjugates were washed seven times with 0.75 
ml 1% NP-40/PBS/KI, and were incubated for 2 rain in a boiling water bath with 80 ul 
Laemmli sample buffer (20) containing 20 mM DTT instead of 2-ME. The supernatant 828  40  KILODALTON NEUTROPHIL Fc  RECEPTOR 
was acetylated by adding 5 #l  1 M iodoacetamide, and was analyzed by SDS-PAGE and 
autoradiography as described (14).  The molecular weight markers included  in all  gels 
were ~'~I-BSA, ~SI-rabbit muscle actin, phosphorylase B, ovalbumin, carbonic anhydrase, 
soybean trypsin inhibitor, and lysozyme. 
Fluorescence and Cell Sorting.  106 cells were incubated for 30 rain at 4°C in 50 #! of 
antibody (either IV3 supernatant or ! 0 #g/ml solutions of purified IgG fractions of ascites 
fluid diluted in RPMI 1640 growth medium containing 10% FCS). The cells were washed 
three times in PBS containing 0. ! % NaNs, were resuspended and incubated for 30 rain 
at 4°C in 50 #l FITC anti-mlg, and were washed a final three times. Freshly stained cells 
were analyzed on an EPICS C flow cytometer (Coulter EPICS Divison, Hialeah, FL) using 
an argon laser at 500  mW power. Green fluorescence was collected through a  525-nm 
bandpass  filter  on  10,000-50,000  cells  gated  for  low  angle  light  scatter  (to  exclude 
erythrocytes, platelets, dead cells,  and debris) and 90 °  light scatter (to exclude residual 
tymphocytes). Three-droplet sorting without coincidence correction at a flow rate of 300- 
500 cells/s was performed at a 32 kHz droplet-formation rate. The sorting logic was based 
on low-angle light scatter and green fluorescence alone, as some interference of the stream 
undulation with the 90 ° light scatter signal was observed. Cells were sorted into a  15-ml 
conical centrifuge tube containing 14 ml Ficoll/Hypaque and 0.5 ml RPMI 1640 culture 
medium with 10% FCS.  After sorting, the supernatant layer of culture medium plus cells 
was aspirated, and the ceils were deposited on a glass slide using a Shandon II cytocentri- 
fuge. The cells were stained with Wright-Giemsa and were analyzed morphologically by 
light microscopy. 
Rosette Assays.  A  1% suspension of PBS-washed ox erythrocytes was incubated with a 
subagglutinating dose of the IgG fraction of a rabbit anti-ox erythrocyte antiserum. In a 
solution of PBS containing 5% heat-inactivated FCS, 25 #l of each antibody (40 #g/ml), 
25  #1  of cells  (4  X  106  cells/ml),  and  50  #1  of a  2%  suspension  of antibody-coated 
erythrocytes were incubated  for  15  rain  at room temperature in  V-bottom microtiter 
wells. The cells were pelleted at 50 g for 1 rain and were incubated for 45 rain at room 
temperature.  Cells  were  resuspended  and  were  evaluated  microscopically at  x  400 
magnification in a hemocytometer for the number of erythrocytes bound to granulocytes. 
In some samples, granulocytes were so covered by bound erythrocytes that they could not 
be visualized; in  these cases the total number of cells was assumed to be the mean for 
those samples where all granulocytes were visualized. 
Superoxide  Generation  Assay.  Continuous  measurement of superoxide-dependent cy- 
tochrome  C  reduction  (21,  22)  was  performed  in  a  Varian  DMS  100  double-beam 
spectrophotometer at 37°C.  In the standard assay, both sample and reference cuvettes 
contained 2 ×  106 granulocytes and 100 nmol ferricytochrome C in 0.95 ml KRP buffer. 
Superoxide dismutase (20 t~g) was present  in the reference cuvette.  All assay mixtures 
were first incubated with cytochalasin B (5 #1 of 1 mg/ml DMSO solution) for 2 rain in 
the presence or absence of inhibitors.  50 #1 of immune complexes (175 #g) were added 
to  both  the  sample and  reference  cuvette,  and  the  absorbance change  accompanying 
cytochrome C reduction  was monitored at 550 nm. The rate of superoxide production 
was calculated from linear rate of absorbance change at 550 nm and the molar extinction 
coefficient for this reduction (21,000) (23). 
Results 
The capacity of mAb 1V3 to bind to neutrophils and eosinophils was evaluated 
by flow cytometry.  Peripheral  blood granulocytes,  incubated  first with  IV3 or 
3G8 and then  with  FITC-anti-mIg, were analyzed for fluorescence with a  flow 
cytometer.  As  seen  in  Fig.  lb,  all  cells  stained  with  IV3  were  of  uniform 
fluorescence  and  were  considerably  brighter  (mean  fluorescence  was  42-fold 
brighter)  than  cells  stained  with  a  murine  IgG2b  (anti-Vr3b),  which  has  no 
specific affinity for granulocytes (Fig.  i a). In contrast, granulocytes stained with 
3G8 (Fig.  1 c) appeared as two populations, one with bright fluorescence and the LOONEY ET AL.  829 
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FIGURE  1.  Indirect immunofluorescence analysis of normal peripheral blood granulocytes. 
(a) Cells stained with a control IgG2b murine mAb, anti-VK3b (50,000 cells counted; full scale, 
1,500 cells/channel). (b) Cells stained with IV3 mAb (50,000  cells counted; full scale, 3,000 
cells/channel).  (c)  Cells  stained  with  3G8  mAb  (175,000  cells  counted;  full  scale,  2,800 
cells/channel).  The  logarithmic green  fluorescence scale  is  expressed  in  arbitrary  units  of 
fluorescence  intensity.  The  3G8  histogram  is  a  composite  of two  analyses  performed  at 
different settings for green fluorescence amplification because a range of only three logs of 
fluorescence intensity can be quantified at one time by the flow cytometer. 
other with dim fluorescence, both considerably brighter than staining seen with 
anti-VK3b  (mean  fluorescence  was,  respectively,  358-fold  and  9-fold  brighter 
than with anti-VK3b). 
In three  experiments on  two individuals with mild hypereosinophilia, these 
two populations of 3G8-stained cells were sorted, fixed onto glass slides, stained 
with Wright-Giemsa, and analyzed microscopically for cell type (Table I). Of the 
brightly fluorescent 3G8-stained cells, nearly all (mean, 96%) were neutrophils, 
whereas  the  dimly fluorescent  3G8-stained  cells were  virtually all  eosinophils 
(mean,  98%).  The percentage of eosinophils in the IV3-stained population of 
cells after staining and sorting was comparable to the percentage of eosinophils 
in the original  unstained cell suspension (Table  I,  Exp.  2),  indicating that the 
eosinophils were not lost during the experimental procedure. We conclude that 
IV3 binds to both neutrophils and eosinophils. 
The nature of the molecule bound by IV3 on granulocytes was analyzed by 
affinity adsorption and PAGE. Purified granulocytes, predominantly neutrophils 
with <5% eosinophils, were radioiodinated and lysed in nonionic detergent with 
or without an additional proteinase inhibitor, diisopropylfluorophosphate (DFP). 
The  lysates  were  incubated  with  affinity  adsorbants  consisting  of Sepharose 
sensitized  with  human  IgG,  IV3,  3G8,  or  a  murine  IgG2b  (MOPC141)  (see 830  40  KILODALTON  NEUTROPHIL  Fc  RECEPTOR 
TABLE  1 
Flow Cytometric Analysis of Granulocytes Stained with 1V3 and 3G8 
Exp.  mAb*  Intensity of staining* 
Cell type  ! 
Cell population  Neutrophils  Eosinophils 
none  --  unsorted  80  20 
IV3  100% bright 
3G8  77% bright  bright sorted  97  3 
23% dim  dim sorted  2  98 
none  --  unsorted  93  7 
IV3  100% bright  bright sorted  92  8 
3G8  89% bright  bright sorted  92  8 
11% dim  dim sorted  0  100 
none  --  unsorted  71  27 
IV3  100% bright 
3G8  83% bright  bright sorted  100  0 
17% dim  dim sorted  1  97 
* Purified granulocytes were incubated first with mAb IV3 or 3G8 and then with FITC-anti-mlg. 
* Antibody-stained cells were analyzed for fluorescence intensity by flow cytometry. 
§ Cells  were  sorted  according  to  the  brightness  of  their  fluorescence.  The  cell  types,  mostly 
neutrophils or eosinophils, in the sorted population were determined microscopically after staining 
with Wright-Giemsa. 
FIGURE 2.  Affinity adsorption  from  lysates of surface-iodinated granulocytes.  ~25I-labeled 
cells were lysed in  1% NP-40 with (+) or without (-) 2 mM DFP.  Portions of the lysate were 
incubated with Sepharose-humao IgG (hlgG) or with IV3 supernatant, 3G8, or MOPC141  (a 
murine IgG2b) at  10 #g/ml, followed by Sepharose-anti-mIg. The eluates from the affinity 
125  adsorbants were analyzed by SDS-PAGE and autoradiography. The lateral lanes contain  1- 
12~  BSA  and  I-actin.  The  positions of Coomassie-stained  molecular  mass  markers  (kD)  are 
indicated by the lateral bars. 
Materials and Methods). Adsorbant-bound proteins were eluted and analyzed by 
SDS-PAGE and autoradiography. Fig. 2 shows that 3G8 bound a heterodisperse 
molecule ranging in molecular mass from 51-73  kD, as (tescribed in an earlier 
publication (8); its size was not altered by the presence of DFP. IV3, in contrast, 
bound a protein of 40 kD in the presence of DFP, and a protein of 33 kD in the LOONEY ET AL. 
TABLE  II 
Percent of Cells Forming Rosettes with IgG-Coated Ox Erythrocytes 
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Exp. 1  Exp. 2  Exp. 3  Exp. 4 
Inhibitor*  Neutro-  K562  Neutro-  Neutro-  Neutro-  Eosino- 
phils*  cells  phils  phils  phils  phils 
~40  ~1  ~4  ~4  ~1  ~4  ~1  ~4  ~1  ~4  ~1 
None  ND  ND  ND  ND  ND  97  97  90  92  37  85 
IV3  91  91  0  90  94  95  97  90  93  0  0 
Fab IV3  ND  ND  ND  ND  ND  81  85  85  87  1  10 
3G8  5  63  100  22  64  12  82  15  68  43  84 
IV3 +  3G8  0  0  ND  1  6  0  4  0  2  0  0 
Fab IV3 +  3G8  ND  ND  ND  ND  ND  0  3  0  2  0  0 
MOPC 141  +  3G8  ND  ND  ND  15  52  16  75  21  72  49  92 
AML-2-23 +  3G8  ND  ND  ND  ND  ND  16  63  ND  ND  ND  ND 
Neutrophils, K562 cells, or eosinophils were incubated with ox erythrocytes sensitized with rabbit 
IgG anti-ox erythrocyte. The percent of cells forming rosettes was determined. 
* Several mAb or their Fab fragments (10 ~g/ml) were added during rosette formation. 
* Neutrophils were ->95% pure. Eosinophils were 98% pure. 
Rosettes were classified as >4 RBC/cell or ~1  RBC/ceII. 
absence of DFP. Immobilized human IgG appeared to bind the proteins purified 
by  both  3G8  and  IV3;  namely, a  broad-based  band  between  51  and  73  kD 
unaltered by the presence of DFP, along with a 33 kD band which in the presence 
of DFP appeared as a 40 kD band. Only background precipitation was seen with 
MOPC141. 
The capacity of IV3 to interfere with an FcR-mediated granulocyte function 
was evaluated by rosette inhibition. As seen in Exp.  1 of Table II, IV3,  when 
added  alone,  resulted  in  little  or  no  inhibition  of rosettes  formed  between 
granulocytes and rabbit IgG-sensitized ox erythrocytes, although K562 rosettes 
were completely inhibited. On the other hand, 3G8 resulted in nearly complete 
inhibition of rosette formation when a rosette was defined as _>4 RBC/celI, but 
less than full inhibition was noted if rosettes were defined as _ 1 RBC/celI. Upon 
the addition of IV3 and 3G8 together, complete inhibition of rosette formation 
was noted. Exps. 2 and 3 (Table II) corroborate the results of Exp. 1, and further 
indicate that the combination of 3G8 plus other murine Ig of the same IgG2b 
subclass as  IV3, either a  myeloma protein (MOPC141)  or an anti-granulocyte 
mAb (AML-2-23),  do not duplicate the additive inhibitory effects of IV3 and 
3G8;  i.e.,  the combinations are  no  more  inhibitory than  3G8  alone.  Exp.  3, 
furthermore, indicates that Fab fragments of IV3 are as effective as the intact 
molecule, suggesting that the inhibitory effect is a direct result of Fab binding 
to the 40 kD molecule precipitated by IV3.  Exp. 4  (Table II), performed with 
purified eosinophils, shows  that rosettes formed with  IgG-coated ox  cells  are 
completely inhibited by IV3, but not at all by 3G8. As shown, Fab fragments of 
IV3  are as  effective as  the intact IgG, eliminating the possibility that the  Fc 
portion of IV3 is interacting with the eosinophil FcR. 
As a  further test of the ability of IV3  to inhibit FcR-mediated granulocyte 
function, we evaluated the effect of IV3 on immune complex-mediated super- 
oxide production. As seen in Fig. 3, the addition of complexes made from tetanus 832  40  KILODALTON NEUTROPH[L  Fc  RECEPTOR 
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FIC,  URE  3.  Time course of granulocyte superoxide (02-) production stimulated by immune 
complexes. Gram]locytes (2 ×  106) incubated with cytochalasin B with and without IV3 mAb 
for 2 rain were stimulated with 175 #g/ml immune complexes at zero time (arrow). Continuous 
measurement of superoxide dismutase-inhibitable cytochrome C reduction was performed as 
described in Materials and Methods. (a) No antibody, (b) IV3 IgG mAb (10 #g/ml), (c) IV3 
Fab fragments (10 ~g/m  0. 
TABLE III 
Effect of mAb on lmmune Complex-stimulated 
Granulocyte Superoxide Production 
02- production 
mAb  (nmol/min/106)  Inhibition (%) 
None  1.75  O 
IV3  0.46  74 
MOPC 141  1.60  8.6 
Anti-VK3b  1.80  -2.9 
AML-2-23  2.12  -21 
Granulocytes incubated with cytochalasin B (5 #g/ml) in the presence or 
absence of each  mAb (10  ~g/ml)  were  stimulated  with 175  ug/ml of 
immune complexes. The initial linear rates of superoxide production were 
measured by computing the slopes of curves, such as those seen in Fig. 3, 
relating cytochrome C reduction  to time. The results are the average of 
duplicate determinations. 
toxin  and  human  IgG anti-tetanus  toxin  to  purified  granulocytes  resulted  in 
prompt release of superoxide  into the  medium, as measured by cytochrome C 
reduction.  The addition of IV3 or Fab fragments of IV3 to the cells before the 
immune complex stimulus completely abrogated superoxide release. Two other 
murine IgG2b proteins (myeloma MOPC 141 and anti-VK3b mAb), and an IgG2b 
mAb (AML-2-23) that binds to  granulocytes were incapable  of duplicating  the 
abrogation  of immune  complex-mediated  superoxide  release  seen  with  IV3 
(Table III). The slight enhancement of superoxide production seen with AML- 
2-23 in Table III is unexplained.  When incubated alone with granulocytes, this 
antibody  was  unable  to  induce  superoxide  production.  In  other  experiments, 
IV3 had no effect on superoxide release mediated by PMA,  Con A, and FMLP 
(data  not  shown),  indicating  that  the  effect of IV3  is specific for the  immune 
complex trigger of superoxide production. 
Discussion 
The principal conclusion to be drawn from these data is that mAb IV3, raised 
against the K562 FcR, defines a  previously undescribed FcR on human neutro- LOONEY ET AL.  833 
phils. The evidence is of three sorts.  First, IV3, which binds to all neutrophils, 
precipitates from neutrophil lysates, a 40 kD molecule virtually identical in size 
to the FcR recently defined on other cell types using this antibody. That is, IV3 
has identified a  40  kD low-affinity FcR for IgG on monocytes and U937  cells 
(I0) and on platelets (12). Normal B cells and cells ofa B cell line (Raft) bear an 
FcR of nearly identical molecular mass to p40 that is not recognized by IV3 (I0, 
24). The 40 kD molecule precipitated by IV3 from neutrophii iysates is obviously 
distinct from the molecule recognized by mAb 3G8 (Fig. 2), which, as previously 
described (8), recognizes a neutrophil FcR with a molecular mass of 51-73 kD. 
Both membrane proteins, the one precipitated by IV3 and the one precipitated 
by 3G8, can be purified using Sepharose-human IgG (Fig. 2), although judging 
from observations with the U937 40 kD receptor (10), Sepharose must be highly 
substituted with IgG to purify the 40 kD molecule. The use of Sepharose-IgG 
having a relatively low IgG/Sepharose ratio likely accounts for prior failures to 
purify the 40 kD molecule from neutrophil lysates (8, 9).  Whether the require- 
ment for high iigand/Sepharose ratio is due to the low affinity of p40 for IgG, 
receptor multivalency, or receptor self-association, needs further evaluation. 
The data of Fig. 2 also indicate that p40 and p51-73 differ in their suscepti- 
bility to proteolytic degradation. In the absence of DFP during detergent lysis 
of the cells, p40  appears as a  33  kD molecule, whereas the molecular mass of 
p51-73 is unaffected by the absence of DFP. In studies of a 43 kD FcR purified 
from eosinophil-enriched populations  (most likely the receptor recognized by 
IV3),  Kulczycki et al.  (9) also found a  33  kD degradation product appearing 
after FcR purification in the absence of DFP. 
The second line of evidence supporting  our contention that  IV3  defines a 
newly recognized FcR on neutrophiis is that the antibody is capable of specifically 
inhibiting  the  binding  of rabbit  IgG-coated  erythrocytes to  neutrophils.  Al- 
though high concentrations (10 #g/ml) of IV3 alone are incapable of inhibiting 
the formation of FcR-dependent rosettes (Table  II),  it  is  quite clear that  the 
partial inhibition seen with 3G8 is made complete by the addition of IV3. That 
is, the two antibodies acting in concert completely inhibit the binding of ligand 
to the neutrophil. We suggest that antibody-coated erythrocytes are binding to 
both molecules, but that the p40  FcR, because of low affinity for its ligand or 
low numbers of receptors per cell, makes a  lesser contribution than p51-73  to 
the formation of rosettes. Two observations indicate that the Fc portion of IV3 
is not inhibiting ligand binding.  First,  Fab fragments of IV3 inhibit rosettes as 
effectively as the intact molecule. Second, other antibodies of the same subclass 
as IV3, including one that binds to a determinant on neutrophils, do not show 
the same synergistic effect in concert with  3G8.  The inhibitory effect of IV3 
most  likely results  from  direct  binding  of IV3  Fab  fragments to  the  ligand- 
binding site on the p40 molecule. 
The third observation indicting p40 is a neutrophil FcR is the capacity of IV3 
to  inhibit  neutrophil  immune complex-mediated superoxide production  (Fig. 
3). This effect, as with rosette formation, was independent of the Fc portion of 
IV3,  Fab fragments of IV3 being sufficient for inhibition.  Moreover, IV3 had 
no effect on superoxide generation by agents other than  immune complexes, 
such as Con A, PMA, and FMLP, indicating that the antibody was interfering 834  40  KILODALTON  NEUTROPHIL  Fc  RECEPTOR 
selectively with  the  FcR-mediated response,  most  likely by  blocking immune 
complex  binding  to  the  cells.  Although  IV3  alone  was  unable  to  stimulate 
superoxide generation, preliminary experiments indicate that crosslinking IV3 
with F(ab')2 fragments ofanti-mIg results in superoxide release from neutrophils. 
How these two molecules, p40 and p51-73, are structurally related to subserve 
FcR-mediated activities is so far unclear. Both seem to be involved in the same 
FcR  functions.  Both  IV3  and  3G8  were required  for complete inhibition  of 
rosette formation,  although  the predominant inhibitory effect was  seen with 
3G8. Although nearly complete inhibition of immune complex-induced super- 
oxide release was caused by IV3, preliminary studies indicate that 3G8, too, is 
capable of inhibiting immune complex-mediated superoxide generation. The 
most  likely explanation  for this  cooperation is  that  p40  and p51-73  are two 
distinct  FcR  that  cooperate  to  bind  opsonized  erythrocytes and  to  generate 
superoxide. 
The second major conclusion to be inferred from the data is that eosinophils 
as well as neutrophils bear a 40 kD FcR recognized by mAb IV3. It is clear from 
the information in Fig. 1 and Table I that eosinophiis, which constitute the 3G8- 
dim population of granulocytes, are recognized by IV3. Moreover, this conclu- 
sion is corroborated by the results of the single experiment with eosinophils in 
Table III, which shows that IV3 but not 3G8 is capable of inhibiting the binding 
of IgG-coated  RBC  to  eosinophils.  Fab  fragments of IV3  are  adequate  for 
inhibition,  suggesting that  IV3  inhibits ligand-receptor interaction by binding 
directly to the receptor. Although we have not determined the molecular mass 
of the molecule(s) precipitated by IV3 from purified eosinophils, Kulczycki (9) 
has described a 43 kD molecule purified by affinity to Sepharose-IgG, which we 
propose is  most likely the FcR recognized by IV3.  Further evaluation of this 
issue is in progress. 
In agreement with Fieit et al. (8), our data in Fig. 1 indicate that 3G8 binds to 
eosinophils,  the mean fluorescence being ninefold brighter than  cells stained 
with anti-VK3b. Other workers, however, have found that eosinophils are nega- 
tive when stained with 3G8 (25). We have no explanation yet for this discrepancy, 
although the sensitivity of the assays and the methods of eosinophil purification 
are obviously different. The single rosette experiment with eosinophils in Table 
IlI indicates that, if the molecule recognized by 3G8 is present on eosinophils, it 
is too sparsely represented to contribute significantly to the binding of opsonized 
erythrocytes. 
Several lines of evidence suggest that the 40 kD FcR recognized by IV3 is the 
human homologue of a  class  of murine receptors recognized by mAb 2.4G2, 
and which on macrophages is termed FcRII (26, 27). (a) p40 on human mono- 
nuclear phagocytes has affinity for mIgG2b and mIgG1, but not for mlgG2a 
(i 0, i I); FcRII on murine macrophages show this same pattern of specificity (27, 
28). (b) Human B cells bear an FcR of ~40 kD, which, at least on the cells of 
one B cell line (Daudi), has serologic crossreactivity with p40 on U937 cells (10); 
2.4G2 recognizes a subset of murine B cells (26). (c) 2.4G2 binds to and inhibits 
FcR function on  murine eosinophiis and neutrophils (29)just  as does IV3  in 
humans, as shown by the data herein. LOONEY ET AL.  835 
Summary 
We describe a  newly recognized 40 kD FcR for IgG on human  neutropbific 
granulocytes. An mAb (IV3) developed against the lgG FcR of K562 cells, and 
specific as well for a  40 kD FcR on human  monocytes and platelets, was found 
to purify by affinity adsorption a 40 kD protein from detergent lysates ofsurface- 
radioiodinated  neutrophils.  This  protein,  proteolytically  degraded  to  33  kD 
when purified in the absence of diisopropylfluorophosphate, is distinct from the 
51-73 kD protein precipitated by the anti-neutrophil FcR mAb, 3G8, previously 
described by others. Complete inhibition of binding of rabbit IgG-coated eryth- 
rocytes to neutrophils  was achieved only when both antibodies,  IV3 and  3G8, 
were  used.  Fab  fragments  of IV3  were  as  effective  inhibitors  as  the  intact 
molecule. IV3 IgG or Fab fragments completely and selectively inhibited immune 
complex-mediated generation of superoxide by human neutrophils; superoxide 
generation  by other stimulants was not abrogated by IV3. This antibody (IV3) 
bound also to human  eosinophils and completely inhibited the binding of IgG- 
coated erythrocytes to eosinophils.  IV3 appears  to define the human  homoiog 
of the murine macrophage FcRII identified initially by mAb 2.4G2 and present 
in the mouse on both neutrophils and eosinophiis. 
We thank Dr. John P. Leddy for a critical review of the manuscript,  and Steven Mitchell 
for expert technical assistance. 
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